Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004. Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. Policy Forum Nov 2008 Uncertainties in the Absence of Data: Use of Pravastatin in Young Children Anna Shifrin and Darshak Sanghavi, MD The AAP’s guidelines on lipid screening for children raise concerns about the fundamental purpose of prevention and its role in balancing individual autonomy with the benefits of society at large. Virtual Mentor. 2008;10(11):747-749. doi: 10.1001/virtualmentor.2008.10.11.pfor1-0811. State of the Art and Science Sep 2003 Depression and Heart Disease Audiey Kao, MD, PhD Virtual Mentor. 2003;5(9):388-389. doi: 10.1001/virtualmentor.2003.5.9.cprl1-0309. State of the Art and Science Jul 2003 Treating Hypertension Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):265-267. doi: 10.1001/virtualmentor.2003.5.7.cprl1-0307. Viewpoint Aug 2002 A Better Perspective: Dr. Alan Heins and the CATCH Program Susanna Smith Virtual Mentor. 2002;4(8):244-245. doi: 10.1001/virtualmentor.2002.4.8.prol1-0208. Case and Commentary Jun 2002 Right to Discontinue Treatment, Commentary 1 Jim Kirkpatrick, MD Virtual Mentor. 2002;4(6):159-163. doi: 10.1001/virtualmentor.2002.4.6.ccas1-0206. Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004.
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.
Policy Forum Nov 2008 Uncertainties in the Absence of Data: Use of Pravastatin in Young Children Anna Shifrin and Darshak Sanghavi, MD The AAP’s guidelines on lipid screening for children raise concerns about the fundamental purpose of prevention and its role in balancing individual autonomy with the benefits of society at large. Virtual Mentor. 2008;10(11):747-749. doi: 10.1001/virtualmentor.2008.10.11.pfor1-0811.
State of the Art and Science Sep 2003 Depression and Heart Disease Audiey Kao, MD, PhD Virtual Mentor. 2003;5(9):388-389. doi: 10.1001/virtualmentor.2003.5.9.cprl1-0309.
State of the Art and Science Jul 2003 Treating Hypertension Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):265-267. doi: 10.1001/virtualmentor.2003.5.7.cprl1-0307.
Viewpoint Aug 2002 A Better Perspective: Dr. Alan Heins and the CATCH Program Susanna Smith Virtual Mentor. 2002;4(8):244-245. doi: 10.1001/virtualmentor.2002.4.8.prol1-0208.
Case and Commentary Jun 2002 Right to Discontinue Treatment, Commentary 1 Jim Kirkpatrick, MD Virtual Mentor. 2002;4(6):159-163. doi: 10.1001/virtualmentor.2002.4.6.ccas1-0206.